Jump to top navigation | Jump to main navigation | Jump to content
Therapeutic Goods Administration logo

Adverse drug reactions: what information to include in a report

The adverse drug reactions reporting form (blue card) <http://www.tga.gov.au/adr/bluecard.htm> provides a good checklist for the information to include in a report. By providing all data relevant to a specific reaction, a rational and objective assessment of the medicine-reaction association can be made by ADRAC professional staff.

All reports should contain the following data:

  • Patient information (initials/UR No, DOB/age)
  • Reporter information (name, address, phone number)
  • A description of the reaction
  • Any medicines suspected of causing the reaction
  • Any other medicines
  • Date of onset of reaction
  • Dates of starting and stopping the suspected medicine
  • Dates of starting and stopping any other medicines
  • Details of any treatment of the reaction
  • Outcome of the reaction and date of the outcome

The following additional data (if available) would be very useful:

  • Medical history
  • Relevant laboratory data (haematology, biochemistry, imaging, serology, biopsy, etc)
  • AUST L number for complementary medicines (this can be identified by the letters "AUST L" followed by some numbers and can be found on the bottle or packaging of the product)
  • Batch number for vaccines and for all cases of suspected quality control (manufacturing fault) problems
  • In cases where the outcome is fatal, the circumstances, date and cause of death. If a postmortem examination or coroner's enquiry was conducted, a copy of the report would also be useful.

Note: If any of the above information is contained in existing documentation (discharge summary, specialist report, laboratory data, etc), it can be provided as photocopies.

Top of page